MEA Molecular Cytogenetics Market

MEA Molecular Cytogenetics Market Size (2023 to 2028)

The size of the Middle East & Africa Molecular Cytogenetics market was worth USD 120.12 million in 2023. It is further expected to grow at a CAGR of 4.5% and value USD 149.65 million by 2028.

Molecular biology and cytogenetics are the two primary fields that are studied under molecular cytogenetics. The study of chromosomes is termed Cytogenetics. Molecular cytogenetics further delves into the analysis of genetic variations and/or alterations through in-situ hybridization techniques.

The CGH technology category commands the largest market share of approximately 53% and is estimated to retain its leading position over the aforementioned forecast period. Rising awareness levels regarding the CGH techniques in molecular biology are likely to raise patient acceptance and widen the application horizon in molecular diagnostics. Also, effective cancer diagnosis because of novel diagnostic biomarkers' characterization coupled with the development of high-resolution, genetic testing platforms that diagnose constitutional and acquired diseases is vital to this market segment's growth.

The rising number of applications regarding the detection of complex chromosomal arrangements using multicolor FISH techniques and SNP-array analysis is another contributing factor for the growth of this segment.

Rising cases of various types of cancer coupled with the rising demand for high-throughput diagnostic tools are expected to boost the molecular cytogenetic technologies' usage rate over the aforementioned forecast period. The personalized medicine segment is poised to widen the therapeutic horizons in delivering enhanced, molecularly guided therapies and precise monitoring of disease progression, thereby leading to this market segment's growth.

This research report on the Middle East and Africa Molecular Cytogenetics Market has been segmented and sub-segmented into the following categories:

By Product:

• Kits & Reagents
  • Testing Kits
  • Probes
  • Fluorescent Affinity Reagents
  • Other Kits & Reagents
• Instruments
• Consumables
• Software & Services

By Technique:

• Comparative Genomic Hybridization
  • Array-Based Comparative Genomic Hybridization
  • Standard Comparative Genomic Hybridization
• Fluorescence in Situ Hybridization
• In Situ Hybridization
• Others

By Application: 

• Genetic Disorders
• Cancer
• Personalized Medicine
• Other Applications

By End User:

• Clinical & Research Laboratories
• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

It is geographically the last in terms of market share, and the UAE is the leading country in this region. It commands a market share of 6%.

Companies playing a leading role in the MEA Molecular Cytogenetics Market profiled in the report are Affymetrix, Inc., Agilent Technologies, Inc., Illumina, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Applied Spectral Imaging, Inc. and Thermo Fisher Scientific (Life Technologies), Inc.